Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:John_Houston
|
| gptkbp:collaboratesWith |
gptkb:Bayer
gptkb:Pfizer |
| gptkbp:developedBy |
PROTAC technology
|
| gptkbp:focusesOn |
neuroscience
oncology protein degradation therapeutics |
| gptkbp:foundedIn |
2013
|
| gptkbp:founder |
gptkb:Craig_Crews
|
| gptkbp:headquartersLocation |
New Haven, Connecticut, United States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Arvinas
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
gptkb:ARV-110
gptkb:ARV-471 |
| gptkbp:numberOfEmployees |
200+
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:ARVN
|
| gptkbp:website |
https://www.arvinas.com/
|
| gptkbp:bfsParent |
gptkb:Craig_Crews
|
| gptkbp:bfsLayer |
6
|